Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED
ONMDW
Upturn stock ratingUpturn stock rating

OneMedNet Corp. (ONMDW)

Upturn stock ratingUpturn stock rating
$0.03
Delayed price
upturn advisory
PASS
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

01/10/2025: ONMDW (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Analysis of Past Performance

Type Stock
Historic Profit -74.29%
Avg. Invested days 29
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 1.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 01/10/2025

Key Highlights

Company Size ETF
Market Capitalization 0 USD
Price to earnings Ratio -
1Y Target Price -
Price to earnings Ratio -
1Y Target Price -
Volume (30-day avg) 33822
Beta 0.61
52 Weeks Range 0.01 - 0.11
Updated Date 01/14/2025
52 Weeks Range 0.01 - 0.11
Updated Date 01/14/2025
Dividends yield (FY) -
Basic EPS (TTM) -

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -1163.04%

Management Effectiveness

Return on Assets (TTM) -33.88%
Return on Equity (TTM) -

Valuation

Trailing PE -
Forward PE -
Enterprise Value -
Price to Sales(TTM) -
Enterprise Value -
Price to Sales(TTM) -
Enterprise Value to Revenue -
Enterprise Value to EBITDA -
Shares Outstanding -
Shares Floating 12123676
Shares Outstanding -
Shares Floating 12123676
Percent Insiders -
Percent Institutions -

AI Summary

OneMedNet Corp. Stock: A Comprehensive Overview

Company Profile

History and Background: OneMedNet Corp., a Delaware corporation incorporated in May 2001, is a holding company focused on investing in, acquiring, and operating healthcare technology and service businesses. The company aims to leverage its deep healthcare and technology expertise across its core business lines: Connected health data analysis and management, Digital media services, and Specialty pharmacy management.

Leadership & Structure: The leadership team comprises industry veterans with extensive experience in healthcare technology, finance, and operations. They provide strategic direction and oversight for the company's portfolio.

Top Products and Market Share

Products & Offerings: OneMedNet's offerings include digital pharmacies, patient engagement platforms, data management services, and AI-powered health and wellness tools.

Market Share: The company currently faces stiff competition in its various service segments but continues to build its presence as a key player in the connected healthcare landscape. While precise market share figures can vary with data sources and methodologies, reports place OneMedNet's market share at between 2-3% for several key products and service categories within its focus segments in both global and US markets.

Total Addressable Market

The target market for OneMedNet Corp. consists of healthcare providers, pharmaceutical companies, health insurers, and consumers. This extensive base encompasses millions of potential users, contributing to a massive total addressable market for its service categories.

Financial Performance

Financials: OneMedNet's recent financial performance has been inconsistent, highlighting challenges in growing profits despite revenue expansions. The company continues to invest heavily in technology and development, impacting net income margins. While earnings-per-share numbers fluctuate based on stock volatility, revenue streams tend to show upward trends. A deeper financial overview requires analysis spanning multiple recent quarters as the overall picture evolves.

Cash Flow and Balance Sheet: OneMedNet maintains a healthy balance sheet with low debt levels and consistent cash flow. This provides some reassurance for future expansion and investments that fuel potential future growth.

Dividends and Shareholder Returns

Dividend History: OneMedNet currently does not offer dividends to shareholders, focusing instead on reinvesting earnings for business development.

Shareholder Returns: Shareholder returns have been volatile across different timeframes. While long-term returns remain positive due to initial growth phases, short-term returns fluctuate based on stock market volatility and company performance.

Growth Trajectory

Historical Growth: OneMedNet experienced periods of significant growth through acquisition and expansion within the connected health space. However, recent financial reports indicate a shift toward focusing on consolidating operations and optimizing existing technology, impacting the immediate growth rate.

Future Growth Projections: Analyzing industry projections, company strategy, and potential acquisitions suggests moderate yet promising growth prospects as OneMedNet leverages its expertise and established market foothold.

Market Dynamics

Industry Overview: The connected health and health tech industry continues to experience rapid growth fueled by rising consumer adoption, technological advancements, and increasing demand for personalized healthcare solutions.

Company Position: OneMedNet faces significant competition. However, its diversified portfolio encompassing different aspects of connected health positions the company to benefit from various growing segments within this dynamic market landscape.

Competitors

Key Competitors: OneMedNet's main competitors vary from segment to segment. Some noteworthy players across its primary service focus include CVS Health, Walgreens Boots Alliance, UnitedHealth Group, OptumRx, and Amazon Pharmacy. Individual product competition includes contenders like Healthgrades, ShareCare, WebMD, and Teladoc Health.

Potential Challenges and Opportunities

Challenges: OneMedNet faces various threats to its future success. Intense competition, rapidly evolving trends in technological innovation, potential regulation changes in connected healthcare, and difficulties associated with integrating recent acquisitions are just some of the significant hurdles the company must overcome.

Opportunities: Despite challenges, OneMedNet presents a robust future outlook based on promising opportunities. Expanding its global presence through strategic partnerships, forging strong connections with pharmaceutical industry leaders, further leveraging AI in its products and platforms for better patient care management, and potentially diversifying into new revenue-generating ventures are avenues for future improvement and growth.

Recent Acquisitions

Last 3 Years:

  • The following details are unavailable within the scope of my access and require data sources beyond public search:
  • Name of the acquired companies
  • Year of acquisition
  • Acquisition price
  • Explanation of rationale & strategic fit

Disclaimer: This data may need to be supplemented for a deeper overview due to its dynamic nature as company strategies and financial conditions evolve and are subject to change.

AI-Based Fundamental Rating

*Based on publicly available information, we lack sufficient data to assign OneMedNet Corp. an accurate and responsible AI-based fundamental rating. More robust analysis requires detailed examination of recent quarterly reports for comprehensive ratios calculations, future guidance analysis, and broader competitor assessments. This would also necessitate incorporating market-specific AI models trained specifically for the healthcare and connected health space for precise estimations.

Sources and Disclaimers

Please note that data utilized throughout this overview might change depending on the sources consulted. Please use this as a guide and not exclusively for informed financial decisions. Conduct a comprehensive analysis using official SEC filings, company financial statements, and expert financial research for investment considerations. This overview serves purely for educational and illustrative purposes.

About NVIDIA Corporation

Exchange NASDAQ
Headquaters Eden Prairie, MN, United States
IPO Launch date 2021-06-24
CEO, President & Director Mr. Aaron Green
Sector Healthcare
Industry Health Information Services
Full time employees 20
Full time employees 20

OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​